Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-6-21
pubmed:abstractText
Generalized social anxiety disorder is a highly prevalent anxiety disorder with deleterious effects on social and family relationships, as well as work performance. We report the results of a multicenter, randomized, placebo-controlled trial comparing the efficacy, safety, and tolerability of fluvoxamine controlled release (CR) to placebo in patients with generalized social anxiety disorder.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0271-0749
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
118-25
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15206657-Adolescent, pubmed-meshheading:15206657-Adult, pubmed-meshheading:15206657-Aged, pubmed-meshheading:15206657-Antidepressive Agents, Second-Generation, pubmed-meshheading:15206657-Anxiety, pubmed-meshheading:15206657-Delayed-Action Preparations, pubmed-meshheading:15206657-Double-Blind Method, pubmed-meshheading:15206657-Female, pubmed-meshheading:15206657-Fluvoxamine, pubmed-meshheading:15206657-Humans, pubmed-meshheading:15206657-Male, pubmed-meshheading:15206657-Middle Aged, pubmed-meshheading:15206657-Psychiatric Status Rating Scales, pubmed-meshheading:15206657-Psychometrics, pubmed-meshheading:15206657-Sample Size, pubmed-meshheading:15206657-Sexual Dysfunction, Physiological, pubmed-meshheading:15206657-Social Behavior Disorders, pubmed-meshheading:15206657-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder.
pubmed:affiliation
Department of Psychiatry, Duke University Medical Center, Trent Drive, 4th Floor, Room 4082B, Durham, NC 27710, USA. jonathan.davidson@duke.edu
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study